{"id":2608,"date":"2026-09-23T12:18:34","date_gmt":"2026-09-23T12:18:34","guid":{"rendered":"https:\/\/nhdbio.com\/?p=2608"},"modified":"2026-09-23T12:18:34","modified_gmt":"2026-09-23T12:18:34","slug":"solucion-de-problemas-relacionados-con-la-inyeccion-en-blanco-de-arrastre-en-los-lc-ms-de-peptidos","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/peptide-lcms-carryover-blank-injection-troubleshooting\/","title":{"rendered":"Arrastre en LC\u2013MS de p\u00e9ptidos: qu\u00e9 indica un blanco con se\u00f1al positiva"},"content":{"rendered":"

A target peak in a blank following a peptide standard is not evidence that the blank contains a new biological signal. Material from the preceding injection may remain in the autosampler, flow path or column. A useful carryover investigation asks where the residual signal originates<\/strong> and how much remains in subsequent blanks under the assay’s actual injection sequence.<\/p>\n

What a neuropeptide Y experiment measured<\/h2>\n

In a published troubleshooting study, researchers injected 1 \u00b5L of 1 \u00b5M neuropeptide Y (NPY)<\/strong> into an LC\u2013Orbitrap system and measured the NPY peak in subsequent blank runs. They defined carryover as the blank-peak abundance divided by abundance in the most recent NPY sample. The first blank was 4.05%<\/strong> of the preceding 1 \u00b5M sample. The same paper reports 0.36%<\/strong> and 0.47%<\/strong> for 5 and 10 \u00b5M NPY standards, respectively, under its tested conditions. A smaller percentage after a higher-concentration injection does not mean less absolute residue; the denominator changed. [1, Results and Discussion, Table 1]<\/p>\n\n\n\n\n\n\n\n
NPY standard, 1 \u00b5L injection<\/th>\nFirst-blank carryover ratio in study<\/th>\nInterpretation boundary<\/th>\n<\/tr>\n<\/thead>\n
1 \u00b5M<\/td>\n4.05%<\/td>\nRatio to that preceding standard’s signal<\/td>\n<\/tr>\n
5 \u00b5M<\/td>\n0.36%<\/td>\nDifferent denominator and possibly different absolute residue<\/td>\n<\/tr>\n
10 \u00b5M<\/td>\n0.47%<\/td>\nAssay-specific ratio, not a universal acceptance limit<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

The investigators then changed parts of the flow path systematically. An experiment avoiding use of the sample needle during a blank reduced the 1 \u00b5M carryover estimate from 4.05% to 3.05%<\/strong>. Further comparisons without the column and after replacing needle and high-pressure valve seals implicated more than one surface. In the paper’s optimized configuration, which included seal replacement and removal of the guard column, the first blank was 2.15%<\/strong> and later blanks were below 0.9%<\/strong>. The 2.15% result cannot be attributed to seal replacement alone. These interventions locate contributions in that instrument; they do not provide a cleaning recipe for every LC\u2013MS platform. [1, \u201cStrategy for identifying carry-over sites,\u201d Experiments 1\u20133 and Table 4]<\/p>\n

A controlled troubleshooting sequence<\/h2>\n

Run a blank after a defined high standard and record the target’s retention time, mass\/transition and signal. Repeat enough blanks to see whether signal decays; do not assume one blank clears it. Check a blank delivered without the normal sample path, where the instrument permits, to separate an ion-source or solvent background from the LC path. Change one component or wash condition at a time<\/strong>: needle path, valve or seal, tubing, guard column and analytical column. Document the same injected mass, blank timing, gradient and integration rule in each comparison.<\/p>\n

Carryover and surface adsorption are related but answer different questions. Adsorption may lower signal in the current sample; later desorption can raise signal in the next blank. A blank can also be contaminated during preparation, so include independently prepared solvent and matrix blanks. Define a method-specific acceptance criterion relative to the lower limit of quantification and intended sample sequence; do not adopt the paper’s 1% target as a universal specification. The LC\u2013MS identity guide<\/a> helps separate identity evidence from a coincident peak.<\/p>\n

Compare the right denominators<\/h3>\n

The NPY paper’s percentages use the preceding sample peak<\/strong> as denominator. For regulatory bioanalytical validation, ICH M10<\/a> instead specifies a blank after the highest calibrator and compares its analyte response with the LLOQ response<\/strong> (and internal-standard response separately). These are different tests; a 2% blank-to-high-standard ratio cannot be judged against the M10 threshold without the LLOQ signal. M10’s published thresholds are 20% of analyte response at LLOQ and 5% of internal-standard response in that context. They are not universal targets for non-regulatory research. [2, \u00a73.2.6]<\/p>\n

Before accepting a run, preserve the sequence: blank before high sample, high sample, first blank, later blanks and next low sample. Record both the blank\/high ratio and blank\/LLOQ ratio when a validated LLOQ exists. This keeps an apparently small percentage from hiding a large bias at the low end.<\/p>\n

Evidence limit<\/h2>\n

This is a single NPY LC\u2013MS setup<\/strong>, not a test of NHD lots or a general performance claim for all peptides. It is valuable for its experimental logic: isolate the source, repeat the blank sequence and verify the effect of each intervention. A laboratory should validate its own wash solvents for compatibility with the column, seals and mass-spectrometer source before implementation.<\/p>\n

Primary source and claim trail<\/h2>\n
    \n
  1. Troubleshooting Carry-Over in the LC-MS Analysis of Biomolecules: The Case of Neuropeptide Y<\/em><\/a>. Mass Spectrometry<\/em>. 2020. DOI 10.5702\/massspectrometry.S0083<\/a>, PMID 33299733. Locations:<\/strong> Results and Discussion\/Table 1 (1 \u00b5L, 1\/5\/10 \u00b5M, ratio definition and 4.05\/0.36\/0.47%); \u201cStrategy for identifying carry-over sites,\u201d Experiments 1\u20133 (needle and column isolation); Table 4 (post-seal-replacement blanks). Primary full text checked.<\/li>\n
  2. International Council for Harmonisation. ICH M10: Bioanalytical Method Validation and Study Sample Analysis<\/em><\/a>, final guideline, 2022. Location:<\/strong> \u00a73.2.6 (carryover definition, blank after ULOQ, LLOQ and internal-standard denominators). Used only as a regulatory comparator, not to reinterpret the NPY experiment.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    A target peak in a blank following a peptide standard is not evidence that the blank contains a new biological signal. Material from the preceding injection may remain in the autosampler, flow path or column. A useful carryover investigation asks where the residual signal originates and how much remains in subsequent blanks under the assay’s […]<\/p>\n","protected":false},"author":1,"featured_media":2607,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"","pim_article_type":"","pim_evidence_level":"","pim_reviewer":"Codex AI-assisted editorial review","pim_reviewed_date":"2026-09-23T20:13:54+08:00","pim_editorial_note":"","pim_review_status":"reviewed","pim_review_reason":"English source and numeric audit, independent seven-language and 135 numeric-exception AI reviews, 70\/70 authenticated localized previews with 2,607\/2,607 body nodes visible, generated-image provenance and visual review, internal-link and private-draft dedup checks completed. Author is existing NHD Technical Team WP user #1. Prepublication SEO fields and expected slug checked; verify public canonical, hreflang, schema, robots and sitemap immediately after this post publishes, and conditionally roll back on failure. Backup is listed in All-in-One WP Migration; full restore was not rehearsed. No human or native-language review was performed. V9 PIM source normalization audit: one trailing ASCII space was removed from 1 source note in the live draft metadata; both source rows remain complete and semantically identical to the reviewed manifest. Manifest PIM SHA e36421dd4ff7c3d906ea4964605eec9e42d161a77a65f4eb6e4d37de2510df8b; live PIM SHA 766320e60d188b44f51ee3c21001418fb7d100ea6bfcdeff74d1ab0785701a71. This is an AI-assisted review, not a claim of human review.","pim_creation_method":"AI-assisted editorial draft; independent Codex source, image and seven-language review; human professional review not claimed","pim_sources":"[{\"title\":\"Troubleshooting Carry-Over in the LC-MS Analysis of Biomolecules: The Case of Neuropeptide Y\",\"url\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7709882\/\",\"note\":\"Source 1. Results and Discussion\/Table 1 (1 \u00b5L, 1\/5\/10 \u00b5M, ratio definition and 4.05\/0.36\/0.47%); \u201cStrategy for identifying carry-over sites,\u201d Experiments 1\u20133 (needle and column isolation); Table 4 (post-seal-replacement blanks).\"},{\"title\":\"International Council for Harmonisation. ICH M10: Bioanalytical Method Validation and Study Sample Analysis, final guideline, 2022. Location: \u00a73.2.6 (carryover definition, blank after ULOQ, LLOQ and internal-standard den\",\"url\":\"https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf\",\"note\":\"Source 2. \u00a73.2.6 (carryover definition, blank after ULOQ, LLOQ and internal-standard denominators). Used only as a regulatory comparator, not to reinterpret the NPY experiment.\"}]","footnotes":""},"categories":[1],"tags":[],"class_list":["post-2608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nPeptide LC\u2013MS Carryover: Diagnose the Blank After a Sample<\/title>\n<meta name=\"description\" content=\"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/solucion-de-problemas-relacionados-con-la-inyeccion-en-blanco-de-arrastre-en-los-lc-ms-de-peptidos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You\" \/>\n<meta property=\"og:description\" content=\"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/solucion-de-problemas-relacionados-con-la-inyeccion-en-blanco-de-arrastre-en-los-lc-ms-de-peptidos\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-23T12:18:34+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1774\" \/>\n\t<meta property=\"og:image:height\" content=\"887\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You\",\"datePublished\":\"2026-09-23T12:18:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\"},\"wordCount\":773,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\",\"name\":\"Peptide LC\u2013MS Carryover: Diagnose the Blank After a Sample\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"datePublished\":\"2026-09-23T12:18:34+00:00\",\"description\":\"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"width\":1774,\"height\":887,\"caption\":\"Conceptual illustration of sample carryover along an autosampler pathway. Not experimental data.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Arrastre en LC\u2013MS de p\u00e9ptidos: qu\u00e9 indica un blanco con se\u00f1al positiva","description":"Un estudio de neurop\u00e9ptido Y rastre\u00f3 el arrastre por aguja, sellos, l\u00edneas y columna; use inyecciones en blanco para localizarlo.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/solucion-de-problemas-relacionados-con-la-inyeccion-en-blanco-de-arrastre-en-los-lc-ms-de-peptidos\/","og_locale":"es_ES","og_type":"article","og_title":"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You","og_description":"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.","og_url":"https:\/\/nhdbio.com\/es\/solucion-de-problemas-relacionados-con-la-inyeccion-en-blanco-de-arrastre-en-los-lc-ms-de-peptidos\/","og_site_name":"NHD","article_published_time":"2026-09-23T12:18:34+00:00","og_image":[{"width":1774,"height":887,"url":"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","type":"image\/png"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You","datePublished":"2026-09-23T12:18:34+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/"},"wordCount":773,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/","url":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/","name":"Arrastre en LC\u2013MS de p\u00e9ptidos: qu\u00e9 indica un blanco con se\u00f1al positiva","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","datePublished":"2026-09-23T12:18:34+00:00","description":"Un estudio de neurop\u00e9ptido Y rastre\u00f3 el arrastre por aguja, sellos, l\u00edneas y columna; use inyecciones en blanco para localizarlo.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","width":1774,"height":887,"caption":"Conceptual illustration of sample carryover along an autosampler pathway. Not experimental data."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/2608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=2608"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/2608\/revisions"}],"predecessor-version":[{"id":2641,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/2608\/revisions\/2641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/2607"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=2608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=2608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=2608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}